What "One Team" Really Means In Drug Development

By Jason Parks, Executive Director, Biotech Operations

Effective drug development depends on more than expertise — it requires true alignment across teams. A “one team” approach emphasizes early, shared decision-making that connects clinical, manufacturing, and supply considerations before challenges surface downstream. Rather than relying on siloed workflows and reactive coordination, this model prioritizes accessibility, transparency, and continuous collaboration.

When teams operate with a unified mindset, information flows more freely, reducing redundancy and preventing late-stage surprises. Conversations happen earlier, issues are identified sooner, and transitions between development phases become smoother. This shift transforms coordination from an invisible burden into an embedded discipline that drives efficiency and clarity.

By integrating capabilities across the development lifecycle, organizations can create an environment where progress is guided by shared understanding—not constant correction. See how this approach is reshaping expectations for speed, quality, and collaboration in modern drug development.